Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Inventory (2018 - 2025)

Historic Inventory for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $5.3 million.

  • Viemed Healthcare's Inventory rose 2222.22% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 2222.22%. This contributed to the annual value of $4.3 million for FY2024, which is 665.51% down from last year.
  • Viemed Healthcare's Inventory amounted to $5.3 million in Q3 2025, which was up 2222.22% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Inventory ranged from a high of $5.3 million in Q3 2025 and a low of $2.2 million during Q1 2021
  • Its 5-year average for Inventory is $3.7 million, with a median of $4.3 million in 2024.
  • As far as peak fluctuations go, Viemed Healthcare's Inventory crashed by 6112.46% in 2021, and later soared by 5688.75% in 2023.
  • Over the past 5 years, Viemed Healthcare's Inventory (Quarter) stood at $2.5 million in 2021, then soared by 45.46% to $3.6 million in 2022, then rose by 29.49% to $4.6 million in 2023, then dropped by 6.66% to $4.3 million in 2024, then grew by 21.97% to $5.3 million in 2025.
  • Its last three reported values are $5.3 million in Q3 2025, $4.3 million for Q2 2025, and $4.5 million during Q1 2025.